These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12020989)

  • 1. [Heparin induced thrombocytopenia: case report with acute thrombotic complications and literature review].
    Plassat R; Cognet F; Ternisien C; Ménoret N; Dubus-Bausière V; Brunel P; Bontoux L; Bernat C; Richard I
    Ann Readapt Med Phys; 2002 May; 45(5):216-23. PubMed ID: 12020989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
    Ranze O; Ranze P; Magnani HN; Greinacher A
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
    Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ardeparin and danaparoid for prevention of deep vein thrombosis.
    Med Lett Drugs Ther; 1997 Oct; 39(1011):94-5. PubMed ID: 9379998
    [No Abstract]   [Full Text] [Related]  

  • 7. Heparin-induced thrombocytopenia: how to manage it, how to avoid it.
    Caiola E
    Cleve Clin J Med; 2000 Sep; 67(9):621-4. PubMed ID: 10992619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
    Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
    Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia].
    Emig U; Meyer T; Buchwald AB
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):965-8. PubMed ID: 9280716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2000 Jul; 6(4):343-51. PubMed ID: 10912644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
    Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonheparin anticoagulants for heparin-induced thrombocytopenia.
    Kelton JG; Arnold DM; Bates SM
    N Engl J Med; 2013 Feb; 368(8):737-44. PubMed ID: 23425166
    [No Abstract]   [Full Text] [Related]  

  • 13. Danaparoid sodium.
    Acostamadiedo JM; Iyer UG; Owen J
    Expert Opin Pharmacother; 2000 May; 1(4):803-14. PubMed ID: 11249517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Wester JP; Haas FJ; Biesma DH; Leusink JA; Veth G
    Intensive Care Med; 2004 Oct; 30(10):1927-34. PubMed ID: 15156309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Am J Cardiovasc Drugs; 2001; 1(6):429-43. PubMed ID: 14728002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
    Salmi L; Leroy-Matheron C; LeBesnerais P; Rosanval O; Duvaldestin P; Gouault-Heilmann M
    Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-induced thrombocytopenia in intensive care patients.
    Selleng K; Warkentin TE; Greinacher A
    Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
    Horlait G; Minet V; Mullier F; Michaux I
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):193-197. PubMed ID: 27100305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S; Jahn UR; Meyer J; Scheld HH; Van Aken H; Kehrel BE; Hammel D
    Ann Thorac Surg; 2000 Mar; 69(3):774-7. PubMed ID: 10750760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.